Community Portal

A place for Clinicians and Healthcare Suppliers to share knowledge and learn more about THE CLINICIAN EXCHANGE



Provided by: Medscape

Patient-Entered Wellness Data Increases Preventive Care

Published: Tue, 17 Oct 2017 12:00:00 EDT
A new tool collects patient-entered data and provides personalized preventive care recommendations in several wellness areas.
Journal of the American Board of Family Medicine

What Counts as Cheating During Medical School Exams?

Published: Tue, 17 Oct 2017 12:00:00 EDT
Intentional or not, sharing information about medical school exams may be considered cheating and could lead to serious repercussions.
Student BMJ

FOXP1-Related Intellectual Disability Syndrome

Published: Tue, 17 Oct 2017 12:00:00 EDT
FOXP1 defects have been implicated in the pathogenesis of intellectual disability and speech and language impairment.
Journal of Medical Genetics

Ketamine vs Ketamine and Propofol for Procedural Sedation

Published: Tue, 17 Oct 2017 12:00:00 EDT
Might the co-administration of ketamine and propofol for pediatric procedural sedation offer additional benefits over ketamine alone?
The Journal of Emergency Medicine
Displaying results 17-20 (of 20)
 1 - 2 - 3 - 4 - 5 


Janssen rolls out trial supply and patient engagement mobile platform

Published: Thu, 12 Oct 2017 09:27:24 +0000
Janssen has tapped into the other side of contracted clinical research to become a service provider, having developed a mobile platform for trial supply management and patient engagement that can track adherence to each pill.

Lilly under legal fire over split from Adocia

Published: Thu, 12 Oct 2017 08:06:31 +0000
Adocia is taking legal action against two-time former partner Eli Lilly. The diabetes biotech wants Lilly to pay up $11 million (€9 million) plus extras to offset perceived harm caused by its changes to the product development plan.

Elligo to test FDA’s real-world data model for immunotherapy safety assessment

Published: Wed, 11 Oct 2017 15:08:36 +0000
Real-world data coming from different sources have limited researchers' ability to analyze them. The FDA has tasked Elligo Health Research to evaluate a harmonized data model the agency built so that those data could talk to each other.

Buoyed by new eczema data, AnaptysBio hits the fundraising button

Published: Wed, 11 Oct 2017 13:46:35 +0000
Just a few months after its $80 million IPO, AnaptysBio is looking to raise another block of cash and accelerate development of its lead drug for atopic dermatitis, also known as eczema.
Displaying results 21-24 (of 25)
 1 - 2 - 3 - 4 - 5 - 6 - 7 

Clinician Owned and Veteran Owned

copyright 2017 THE CLINICIAN EXCHANGE. Privacy Policy